SEC EDGAR — 8-K filingsUnited States6 October 2026
8-K - ACURA PHARMACEUTICALS, INC (0000786947) (Filer)
This is an official announcement record
Firsthand records what SEC EDGAR — 8-K filings announced and links to the original. The wording below is theirs, not ours.
Filed: 2026-10-06 AccNo: 0001104659-26-114055 Size: 227 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Read the official announcement
Opens www.sec.gov
More from SEC EDGAR — 8-K filings
- 8-K - Fossil Group, Inc. (0000883569) (Filer)6 October 2026
- 8-K - Granite Point Mortgage Trust Inc. (0001703644) (Filer)6 October 2026
- 8-K - Voya Financial, Inc. (0001535929) (Filer)6 October 2026
- 8-K - NEXTERA ENERGY INC (0000753308) (Filer)6 October 2026
- 8-K - Southern Cross Acquisition II Corp. (0002133239) (Filer)6 October 2026
This content is for informational purposes only and is not financial, investment, tax, or legal advice. Rates, fees, and terms change and may differ from what is shown here; verify current details with the provider before acting. Consider consulting a qualified financial professional about your specific situation.